A case of nivolumab-induced scleroderma-like syndrome successfully treated with intravenous immunoglobulin
oleh: Alexa DeMaio, MD, Kimberly B. Hashemi, MD, Alexandria Avery, MD, John S. Metcalf, MD, Laura S. Winterfield, MD, MPH
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2023-01-01 |
Deskripsi
Subjek
checkpoint inhibitor; immune-related adverse event; IVIG; scleroderma-like syndrome